Baldwin Investment Management LLC Sells 135 Shares of CME Group Inc. (NASDAQ:CME)

Baldwin Investment Management LLC decreased its holdings in shares of CME Group Inc. (NASDAQ:CME) by 2.4% during the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 5,390 shares of the financial services provider’s stock after selling 135 shares during the quarter. Baldwin Investment Management LLC’s holdings in CME Group were worth $1,189,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of CME. New Covenant Trust Company N.A. bought a new position in shares of CME Group in the 1st quarter worth $82,000. Citizens Financial Group Inc. RI raised its stake in shares of CME Group by 8.0% during the 1st quarter. Citizens Financial Group Inc. RI now owns 1,078 shares of the financial services provider’s stock worth $232,000 after acquiring an additional 80 shares in the last quarter. Virtu Financial LLC purchased a new stake in CME Group during the first quarter valued at approximately $2,488,000. Sanibel Captiva Trust Company Inc. boosted its stake in CME Group by 0.9% in the first quarter. Sanibel Captiva Trust Company Inc. now owns 17,060 shares of the financial services provider’s stock valued at $3,673,000 after acquiring an additional 150 shares in the last quarter. Finally, Swedbank AB purchased a new position in CME Group in the first quarter worth $15,017,000. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Insider Activity

In other CME Group news, insider Timothy Francis Mccourt sold 1,374 shares of the stock in a transaction that occurred on Monday, October 28th. The stock was sold at an average price of $227.12, for a total transaction of $312,062.88. Following the transaction, the insider now owns 7,275 shares in the company, valued at approximately $1,652,298. This represents a 15.89 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Martin J. Gepsman sold 400 shares of the business’s stock in a transaction that occurred on Monday, November 4th. The shares were sold at an average price of $222.92, for a total value of $89,168.00. Following the completion of the sale, the director now owns 25,067 shares of the company’s stock, valued at $5,587,935.64. This trade represents a 1.57 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 15,621 shares of company stock valued at $3,441,063 in the last three months. 0.30% of the stock is currently owned by corporate insiders.

CME Group Price Performance

NASDAQ:CME opened at $234.39 on Wednesday. The firm’s fifty day moving average is $224.18 and its two-hundred day moving average is $211.37. The firm has a market cap of $84.46 billion, a price-to-earnings ratio of 24.65, a PEG ratio of 5.29 and a beta of 0.55. CME Group Inc. has a one year low of $190.70 and a one year high of $235.18. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, topping analysts’ consensus estimates of $2.65 by $0.03. The firm had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.59 billion. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The company’s revenue was up 18.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.25 earnings per share. Research analysts expect that CME Group Inc. will post 10.22 EPS for the current year.

CME Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Monday, December 9th will be issued a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a dividend yield of 1.96%. The ex-dividend date of this dividend is Monday, December 9th. CME Group’s dividend payout ratio (DPR) is 48.37%.

Analyst Ratings Changes

Several analysts have recently commented on CME shares. Piper Sandler increased their price objective on CME Group from $240.00 to $250.00 and gave the company an “overweight” rating in a report on Monday, October 28th. Deutsche Bank Aktiengesellschaft lowered their price target on CME Group from $227.00 to $226.00 and set a “hold” rating for the company in a report on Monday, November 11th. TD Cowen started coverage on shares of CME Group in a report on Thursday, September 26th. They set a “hold” rating and a $221.00 price objective on the stock. The Goldman Sachs Group lifted their target price on shares of CME Group from $195.00 to $198.00 and gave the stock a “sell” rating in a research note on Thursday, October 3rd. Finally, Barclays upped their price target on shares of CME Group from $219.00 to $231.00 and gave the company an “equal weight” rating in a research note on Thursday, October 24th. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have issued a buy rating to the stock. According to MarketBeat, CME Group has an average rating of “Hold” and a consensus target price of $224.47.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.